Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophy

Movement Disorders

Volumn 22, Issue 2, 2007, Pages 174-178

  Löscher, Wolfgang N ^a   Stampfer Kountchev, Michaela ^a   Sawires, Martin ^a   Seppi, Klaus ^a   Mueller, Joerg ^a   Szubski, Christoph ^a   Hirnsperger, Katrin ^a   Brenneis, Christian ^a   Poewe, Werner ^a   Wenning, Gregor K ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Motor evoked potential; Silent period; Transcranial magnetic stimulation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MOTOR CORTEX; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME; TRANSCRANIAL MAGNETIC STIMULATION;

ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; MUSCLE, SKELETAL; SEVERITY OF ILLNESS INDEX; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 33847749390     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21242     Document Type: Article

References (25)

1. Su M, Yoshida Y, Hirata Y, Watahiki Y, Nagata K. Primary involvement of the motor area in association with the nigrostriatal pathway in multiple system atrophy: neuropathological and morphometric evaluations. Acta Neuropathol (Berl) 2001;101:57-64.
2. Wakabayashi K, Ikeuchi T, Ishikawa A, Takahashi H. Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter. J Neurol Sci 1998;156:114-117.
3. Brenneis C, Seppi K, Schocke MF, et al. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 2003;18:1132-1138.
4. Cantello R. Applications of transcranial magnetic stimulation in movement disorders. J Clin Neurophysiol 2002;19:272-293.
5. Lefaucheur JP. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 2005;116:244-253.
6. Abbruzzese G, Marchese R, Trompetto C. Sensory and motor evoked potentials in multiple system atrophy: a comparative study with Parkinson's disease. Mov Disord 1997;12:315-321.
7. Cruz Martinez A, Arpa J, Alonso M, Palomo F, Villoslada C. Transcranial magnetic stimulation in multiple system and late onset cerebellar atrophies. Acta Neurol Scand 1995;92:218-224.
8. Kuhn AA, Grosse P, Holtz K, Brown P, Meyer BU, Kupsch A. Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes. Clin Neurophysiol 2004;115:1786-1795.
9. Marchese R, Trompetto C, Buccolieri A, Abbruzzese G. Abnormalities of motor cortical excitability are not correlated with clinical features in atypical parkinsonism. Mov Disord 2000;15:1210-1214.
10. Wolters A, Classen J, Kunesch E, Grossmann A, Benecke R. Measurements of transcallosally mediated cortical inhibition for differentiating parkinsonian syndromes. Mov Disord 2004;19:518-528.
11. Manfredi L, Garavaglia P, Beretta S, Pellegrini G. Increased cortical inhibition induced by apomorphine in patients with Parkinson's disease. Neurophysiol Clin 1998;28:31-38.
12. Gilio F, Curra A, Inghilleri M, Lorenzano C, Manfredi M, Berardelli A. Repetitive magnetic stimulation of cortical motor areas in Parkinson's disease: implications for the pathophysiology of cortical function. Mov Disord 2002;17:467-473.
13. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
14. Berardelli A, Inghilleri M, Rothwell JC, et al. Facilitation of muscle evoked responses after repetitive cortical stimulation in man. Exp Brain Res 1998;122:79-84.
15. Wichmann T, DeLong MR. Functional neuroanatomy of the basal ganglia in Parkinson's disease. Adv Neurol 2003;91:9-18.
16. Brooks DJ, Ibanez V, Sawle GV, et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184-192.
17. Sanger TD, Garg RR, Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol 2001;530(Pt 2):307-317.
18. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol 1999;517(Pt 2):591-597.
19. Berardelli A, Rona S, Inghilleri M, Manfredi M. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain 1996;119(Pt 1):71-77.
20. Romeo S, Gilio F, Pedace F, et al. Changes in the cortical silent period after repetitive magnetic stimulation of cortical motor areas. Exp Brain Res 2000;135:504-510.
21. Rothwell JC, Thompson PD, Day BL, Boyd S, Marsden CD. Stimulation of the human motor cortex through the scalp. Exp Physiol 1991;76:159-200.
22. Chen R, Lozano AM, Ashby P. Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings. Exp Brain Res 1999;128:539-542.
23. Roick H, von Giesen HJ, Benecke R. On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects. Exp Brain Res 1993;94:489-498.
24. Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994;117(Pt 2):317-323.
25. Ziemann U, Bruns D, Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci Lett 1996;208:187-190.